🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective * To evaluate the safety and tolerability of co-administ...
Status
Completed
Location
Faculty of Tropical Medicine
Start Date
2015-10
Trial ID
NCT02568098
Treatments Being Tested
This is a prospective, open label, randomised controlled trial to assess th...
Status
Completed
Location
Primary health centres
Start Date
2015-01
Trial ID
NCT02325180
Treatments Being Tested
The work will be conducted in six health posts in the regions of Matam (Kan...
Status
Completed
Location
six health posts in Kanel, Linguère and Ranérou districts
Start Date
2015-09
Trial ID
NCT02536222
Treatments Being Tested
Malaria is the most important human parasitic disease and is responsible of...
Status
Completed
Location
ISSR/Centre Muraz
Start Date
2010-06
Trial ID
NCT00852423
The aim of the study is to determine whether piperaquine plus dihydroartemi...
Status
Completed
Location
IRSS
Start Date
2009-07
Trial ID
NCT00941785
The main goal of this study is to assess the efficacy of RTS,S/AS01E, a can...
Status
Completed
Location
Lucas O Tina
Start Date
2020-11-06
Trial ID
NCT04661579
The main objective is to compare the safety and efficacy of 4 artemisinin-b...
Status
Completed
Location
Centre Muraz/IRSS
Start Date
2007-07
Trial ID
NCT00393679
In this study, the investigators are interested to know if lower doses of P...
Status
Completed
Location
Medical Research Council Unit (MRC), The Gambia
Start Date
2013-08
Trial ID
NCT01838902
The antimalarial drugs efficacy and safety study will be conducted in the C...
Status
Completed
Location
CDC Hospital
Start Date
2013-01
Trial ID
NCT02974348
This study aims to evaluate the effectiveness of the use of adapted insecti...
Status
Suspended
Location
Daaras in Touba
Start Date
2024-01-19
Trial ID
NCT06225297
Treatments Being Tested